A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
No news articles
via Google News
The Latest on: Skin cancer
- Fears cancer checks in a holding pattern during pandemicon May 11, 2020 at 5:02 am
MELANOMA experts are worried skin checks have been put into a holding pattern during the coronavirus pandemic, with many people avoiding trips to their doctors.
- Bristol Myers Squibb Research at ASCO Demonstrates Diverse Approaches in Treating Cancer to Improve Outcomes for Patientson May 11, 2020 at 4:28 am
Bristol Myers Squibb Research at ASCO Demonstrates Diverse Approaches in Treating Cancer to Improve Outcomes for Patients ...
- Ultraviolet C light is not safe to use on your skin to kill coronaviruson May 9, 2020 at 3:00 am
New research has shown that UVC light could effectively deactivate the novel coronavirus on surfaces and medical equipment such as respirators, personal protective equipment (PPE), and hospital floors ...
- Westport dermatologist emphasizes importance in skin checkups during Skin Cancer Awareness Monthon May 7, 2020 at 1:43 am
May is Skin Cancer Awareness Month and a Westport dermatologist wants to make sure her patients can be seen and heard during the pandemic, even if it is virtually.
- Duane 'Dog' Chapman Reveals He Had A Recent Skin Cancer Scare That Required Minor Surgeryon May 6, 2020 at 8:09 am
Duane 'Dog' Chapman Congratulated By His Friend Sharon Stone For His Engagement To Francie Frane. Duane 'Dog The Bounty Hunter' Chapman's Daughter Defends Him Against People Attac ...
- Former beauty queen diagnosed with rare form of skin cancer after discovering dark line on her thumbnailon May 5, 2020 at 12:56 pm
A former beauty queen is sharing her story of how she developed skin cancer from an unlikely source: gel polish manicures. Karolina Jasko was just a senior in high school when a nail technician ...
- CURE™ Speaking Out Launches Video Series in Recognition of Skin Cancer Awareness Monthon May 4, 2020 at 8:34 am
In support of Skin Cancer Awareness Month, the CURE ™ Speaking Out video series unveiled a four-episode discussion titled, "Raising Awareness Around Skin Cancer," featuring Jeremy A. Brauer, M.D., an ...
- Why this form of skin cancer strikes men harder than womenon May 3, 2020 at 9:06 pm
While early detection ensures a 99 percent five-year survival rate of this usually slow-growing cancer, melanoma remains the most fatal form.
- Shun the Sun to Prevent Skin Canceron May 2, 2020 at 7:13 am
Protecting yourself from exposure to sunlight is the best way of preventing skin cancer, according to the American Academy of Dermatology (AAD). The results of the AAD survey show that 76% of ...
- UHB and Skin Analytics launch new skin cancer community assessment serviceon April 30, 2020 at 8:55 am
University Hospitals Birmingham NHS Foundation Trust and AI specialist Skin Analytics are to pilot a new skin cancer community assessment service to safely reduce delays in skin cancer detection and ...
via Bing News